At Lonza we always welcome interest and inquiries from the media about our business, services and capabilities. Please use the resources on this page, or contact our media relations team for specific inquiries, and we will connect you to the appropriate business leader or subject matter expert.

18 May 2021
Lonza Launches Next Generation 4D-Nucleofector Cell Transfection Platform with...
Lonza launches next-generation 4D-Nucleofector® Platform, the leading non-viral cell transfection method for a wide variety of cell types – even those traditionally hard to...
19 January 2022
Lonza Drug Product Services Participates in the RealHOPE Project to Assess and...
Lonza Drug Product Services is participating in the RealHOPE project to identify critical factors contributing to protein instability during handling The program aims to...
12 October 2021
Capital Markets Day 2021: Lonza to Capture Market Demand and Ensure Sustainable...
At its Capital Markets Day, Lonza outlined strategic priorities and innovation highlights with a clear focus on sustainable value creation Accelerated, de-risked, long-term...